Keywords: nordisk, signs, french, blood, clot, drug, accord

Nordisk signs French blood clot drug accord

Article | 18 February 2008

Print This

Danish insulin giant Novo Nordisk has entered a global licence agreement with French biotechnology company C2X Pharma and France's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in